ECM
PFE icon

Eisler Capital Management’s Pfizer PFE Stock Holding History

Eisler Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3.69M Hold
144,900
– – 0.02% 400
2025
Q2 		$3.51M Sell
144,900
-120,700
-45% -$2.81M 0.02% 451
2025
Q1 		$6.73M Sell
265,600
-87,300
-25% -$2.28M 0.05% 385
2024
Q4 		$9.39M Buy
+352,900
New +$9.57M 0.04% 320

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Eisler Capital Management's PFE Position: Q3 2025 in Review

Eisler Capital Management reduced its Pfizer (PFE) stake by 14% in Q3 2025, selling an estimated $445K and leaving 113,223 shares worth $2.88M. The position accounts for 0.01% of the portfolio, ranked #440.

Eisler Capital Management first reported a position in PFE in Q4 2024 and has held it in 4 quarters since. The position peaked at $5.54M in Q4 2024. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Eisler Capital Management held 113,223 shares of Pfizer worth $2.88M as of Q3 2025.
  • Eisler Capital Management sold 18,039 Pfizer shares in Q3 2025, an estimated $445K.
  • Pfizer made up 0.01% of Eisler Capital Management's portfolio in Q3 2025, its #440 holding.
  • Eisler Capital Management first reported a position in Pfizer in Q4 2024 and has held it in 4 quarters since.
  • Eisler Capital Management's Pfizer position peaked at $5.54M in Q4 2024.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Eisler Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.